Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.

British journal of cancer - 7 Jul 2009

Armaou S, Pertesi M, Fostira F, Thodi G, Athanasopoulos P S, Kamakari S, Athanasiou A, Gogas H, Yannoukakos D, Fountzilas G, Konstantopoulou I

Abstract excerpt

BACKGROUND: In most Western populations, 5-10% of all breast cancer cases can be attributed to major genetic factors such as predisposing mutations in BRCA1 and BRCA2, with early-onset cases generally considered as an indicator of genetic susceptibility. Specific BRCA1 and BRCA2 mutations or different mutation frequencies have been identified in specific populations and ethnic groups. Previous studies in Greek...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Genes, BRCA1

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Greece

Source

Open in PubMed Open full text

Identifiers

PMID: 19491894
DOI: 10.1038/sj.bjc.6605115
PMCID: PMC2713692

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.PMID 19491894Read ↗

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Semantic proximity Read ↗

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.Semantic proximity Read ↗

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.Semantic proximity Read ↗

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.Semantic proximity Read ↗

BRCA2 gene mutations in Greek patients with familial breast cancer.Semantic proximity Read ↗

BRCA1 mutation analysis in breast/ovarian cancer families from Greece.Semantic proximity Read ↗

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.Semantic proximity Read ↗

Distribution and prevalence of germline mutations in patients with early breast cancer and their correlation with disease-free survival: Real-world clinical practice data in North GreeceSemantic proximity Read ↗

Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece.Semantic proximity Read ↗

Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.Semantic proximity Read ↗

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.Semantic proximity Read ↗

One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility geneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.